Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 3
2016 4
2017 5
2018 8
2019 8
2020 16
2021 19
2022 21
2023 10
2024 13
2025 11
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean signor iello e (31 results)?
Therapeutic Plasmapheresis: A Revision of Literature.
Altobelli C, Anastasio P, Cerrone A, Signoriello E, Lus G, Pluvio C, Perna AF, Capasso G, Simeoni M, Capolongo G. Altobelli C, et al. Among authors: signoriello e. Kidney Blood Press Res. 2023;48(1):66-78. doi: 10.1159/000528556. Epub 2022 Dec 8. Kidney Blood Press Res. 2023. PMID: 36481657 Free PMC article. Review.
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis.
De Rosa G, Russo C, Garavelli S, Di Silvestre D, Spatocco I, Mele G, La Rocca C, Colamatteo A, Carbone F, Fusco C, Passaro F, Carpi D, Tagliabue E, Prattichizzo F, Brambilla F, Mauri P, Hoxha M, Bollati V, Giusti I, Dolo V, D'Antona P, Campomenosi P, Mangolini V, Radeghieri A, Bergese P, Morabito I, Mandelli A, Finardi A, Beretta F, Schilke ED, Cavaletti G, Dolcetti E, Buttari F, Abbadessa G, Bonavita S, Lus G, Signoriello E, Lanzillo R, Morra VB, Mottola M, Zuccarelli B, Uccelli A, Salvetti M, Centonze D, Furlan R, Matarese G, Procaccini C, de Candia P. De Rosa G, et al. Among authors: signoriello e. Sci Transl Med. 2025 May 28;17(800):eadl1698. doi: 10.1126/scitranslmed.adl1698. Epub 2025 May 28. Sci Transl Med. 2025. PMID: 40435218
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.
Novi G, Bovis F, Sciolla C, Frau J, Minetti M, Napoli F, Vianello M, Greco G, Sechi E, Bellomo A, Garelli P, Spiezia AL, Fantozzi R, Schirò G, Ghezzi L, Zecca C, Signoriello E, Brambilla L, Lucchini M, Bonavita S, Schiavetti I, Malentacchi M, Cocco E, Franceschini A, Mataluni G, Gastaldi M, Rolando A, Solla P, Cellerino M, Abbadessa G, Lanzillo R, Di Sapio A, Uccelli A, Sormani MP. Novi G, et al. Among authors: signoriello e. CNS Drugs. 2025 Jul;39(7):693-705. doi: 10.1007/s40263-025-01191-7. Epub 2025 May 29. CNS Drugs. 2025. PMID: 40442445
Disability assessment using Google Maps.
Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Lavorgna L, et al. Among authors: signoriello e. Neurol Sci. 2022 Feb;43(2):1007-1014. doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17. Neurol Sci. 2022. PMID: 34142263 Free PMC article.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
Zanghì A, Borriello G, Bonavita S, Fantozzi R, Signoriello E, Barone S, Abbadessa G, Cellerino M, Ziccone V, Miele G, Lus G, Valentino P, Bucello S, Inglese M, Centonze D, Avolio C, D'Amico E. Zanghì A, et al. Among authors: signoriello e. J Neurol. 2024 Jul;271(7):4495-4502. doi: 10.1007/s00415-024-12360-x. Epub 2024 May 4. J Neurol. 2024. PMID: 38704488 Free PMC article.
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.
Landi D, Bartolomeo S, Bovis F, Amato MP, Bonavita S, Borriello G, Buccafusca M, Bucello S, Cavalla P, Cellerino M, Centonze D, Cocco E, Conte A, Cortese A, D'Amico E, Di Filippo M, Docimo R, Fantozzi R, Ferraro E, Filippi M, Foschi M, Gallo A, Granella F, Ianniello A, Lanzillo R, Lorefice L, Lucchini M, Lus G, Mataluni G, Mirabella M, Moiola L, Napoli F, Nicoletti CG, Patti F, Ragonese P, Realmuto S, Schirò G, Signoriello E, Sinisi L, Stromillo ML, Tomassini V, Vecchio D, Sormani MP, Marfia GA. Landi D, et al. Among authors: signoriello e. Mult Scler. 2024 Oct;30(11-12):1503-1513. doi: 10.1177/13524585241274600. Epub 2024 Sep 12. Mult Scler. 2024. PMID: 39263885
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
Maniscalco GT, Sparaco M, Di Gregorio M, Cafasso G, Signoriello E, Romano F, Iodice R, Fantozzi R, Bellantonio P, Zanghi A, Sinisi L, D'Ambrosio A, Busillo V, Scarano V, Capuano R, Lavorgna L, Williams M, De Martino A, Di Battista ME, Di Giulio Cesare D, Lus G, Cassano E, Di Filippo PS, Sibilia G, Abbadessa G, Andreone V, Bonavita S. Maniscalco GT, et al. Among authors: signoriello e. J Neurol. 2025 Aug 6;272(9):559. doi: 10.1007/s00415-025-13300-z. J Neurol. 2025. PMID: 40770143 Free PMC article.
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis.
De Felice B, Signoriello E, Montanino C, Romano G, Archetto D, Maida E, Marciano M, Bonavita S, Lus G, Farinella F, Coppola C. De Felice B, et al. Among authors: signoriello e. Noncoding RNA Res. 2025 May 15;13:174-183. doi: 10.1016/j.ncrna.2025.05.009. eCollection 2025 Aug. Noncoding RNA Res. 2025. PMID: 40510879 Free PMC article.
Switch from fingolimod to ozanimod for safety or intolerance reasons.
Signoriello E, Romano G, Foschi M, Zanghì A, D'Amico E, Fantozzi R, Centonze D, Lus G. Signoriello E, et al. Ther Adv Neurol Disord. 2025 Jul 9;18:17562864251328191. doi: 10.1177/17562864251328191. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 40655996 Free PMC article.
105 results